Specialty medications are used to treat conditions like multiple sclerosis, cancer and rheumatoid arthritis. These medications can be life-changing, but they can also come with complicated treatment ...

ST. LOUIS, April 16, 2019 /PRNewswire/ -- Express Scripts today announced that its specialty pharmacy, Accredo, will open a new location in Honolulu to provide high-touch pharmacy care to people ...

LA JOLLA, Calif.--(BUSINESS WIRE)--Trio Health announced today that Accredo Specialty Pharmacy will collaborate with Trio Health on their proprietary technology and analytics platform to provide real ...

At Accredo—Express Scripts’ specialty pharmacy subsidiary—the COVID-19 pandemic has revealed significant opportunities to bolster its existing digital tools. For one, that’s meant being prepared to ...

Tricare beneficiaries with prescriptions for specialty drugs can now get more of them at the lower copays of Tricare Home Delivery with the addition of Accredo, a specialty pharmacy, to the program.

Patients living with rare diseases often endure a winding path to a diagnosis – and an equally long road to finding a rhythm with their treatments. Symptoms evolve, therapies can be intensive, and ...

BLOOMFIELD, Conn., April 25, 2024 /PRNewswire/ -- In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services ...

Medco Health Solutions Inc., one of the nation’s biggest pharmacy benefits managers, said Wednesday that it would buy Accredo Health Inc., a distributor of specialty drugs and services, in a ...

In this episode, Becker’s Healthcare speaks with Jim Blondin, Senior Director of Digital Product Strategy at Accredo Specialty Pharmacy, about the strategic benefits of integrating specialty pharmacy ...

Add Yahoo as a preferred source to see more of our stories on Google. Tricare beneficiaries with prescriptions for specialty drugs can now get more of them at the lower copays of Tricare Home Delivery ...

High- and low-concentration interchangeable biosimilar will be available, estimated to save individual patients around $3,500 on average per year Biosimilar price will be about 85% lower than Humira ® ...